Concepedia

Linda Stertman

LS

15

Publications

1.2K

Citations

13

H-Index

2004

Active since

Affiliations

Novavax (Sweden)(Current)

Uppsala University

Novavax (United States)

Catalent (United States)

University of Oklahoma Health Sciences Center

Linda Stertman is an author at Novavax (Sweden) specializing in medicine, immunology, and vaccination.

ORCID

Top concepts

Publications per year

2004–2021

15

Publications

15

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Jing-Hui Tian, Nita Patel, Robert Haupt et al. · Nature Communications · 2021 · 517 citations · Full text

Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman et al. · Vaccine · 2016 · 126 citations · Full text

Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen

Jenny M. Reimer, Karin H. Karlsson, Karin Lövgren‐Bengtsson et al. · PLoS ONE · 2012 · 124 citations · Full text

Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice

Sofia Magnusson, Arwen F. Altenburg, Karin Lövgren Bengtsson et al. · Immunologic Research · 2018 · 76 citations · Full text

Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice

Sofia Magnusson, Jenny M. Reimer, Karin H. Karlsson et al. · Vaccine · 2013 · 72 citations

, , +9

Rows per page

1–5 of 15